Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

T-Switch: A specificity-based engineering platform for developing safe and effective T cell therapeutics

Immunity(2024)10.1016/j.immuni.2024.11.009Source: DataRank Database

T-Switch: A specificity-based engineering platform for developing safe and effective T cell therapeutics is a research paper published in Immunity (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.58)OA: hybridTopics (26)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Tomasz Kula ORCID,Stephen J. Elledge ORCID,Nouran S. Abdelfattah ORCID

Live enrichment

PubMed:39631392 OpenAlex:https://openalex.org/W4404961842

National Cancer Institute Division of Cancer Epidemiology and Genetics

Grant: R01CA234600

National Institutes of Health

Grant: F99CA264312

Mark Foundation For Cancer Research

Grant: CGCATF-2023/100005

Howard Hughes Medical Institute

National Cancer Institute Division of Cancer Epidemiology and Genetics

Howard Hughes Medical Institute

FWCI

1.58

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.immuni.2024.11.009

publisherhttps://doi.org/10.1016/j.immuni.2024.11.009

publisherhttps://api.elsevier.com/content/article/PII:S1074761324005247?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1074761324005247?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39631392

Fields of Study

CAR-T cell therapy researchHumansReceptors, Antigen, T-CellT-LymphocytesImmunotherapy, AdoptiveAutoantigensAnimalsPeptidesAntigens, NeoplasmT-Cell Antigen Receptor Specificity

MeSH Terms

AnimalsAntigens, NeoplasmAutoantigensHumansPeptidesReceptors, Antigen, T-CellT-LymphocytesImmunotherapy, AdoptiveT-Cell Antigen Receptor Specificity

Keywords

BiologyComputational biologyCancer researchT cellsSelf-reactivityEpitope SpecificityTcr Evolution